New Findings on Corticobasal Degeneration from Stanford Neurosciences Health Center Summarized (Diagnosis and Management of Progressive Corticobasal Syndrome).

A recent report from the Stanford Neurosciences Health Center discusses the clinical, radiological, and neuropathological heterogeneity of corticobasal syndrome (CBS), which can complicate accurate diagnosis and treatment decisions. The most common diagnosis is corticobasal degeneration (CBD), but there are other underlying pathologies that can overlap with other neurodegenerative diseases. The report highlights the importance of early detection and accurate diagnosis for initiating early management and enrollment in clinical trials. The development of fluid and imaging biomarkers is driving research forward and instilling optimism for creating more effective disease-modifying treatments for brain proteinopathies. [Extracted from the article]